Exogenous High-mobility group box 1 protein injection improves cardiac function after myocardial infarction: Involvement of Wnt signaling activation

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Zhou, Xiaoya ^a   Hu, Xiaorong ^a   Xie, Jing ^a   Xu, Changwu ^a   Xu, Weipan ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COLLAGEN; DISHEVELLED 1; HIGH MOBILITY GROUP B1 PROTEIN; WNT PROTEIN; CARDIOTONIC AGENT; CATNB PROTEIN, RAT; DISHEVELLED PROTEINS; MESSENGER RNA; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROTECTION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; WNT SIGNALING PATHWAY; ANALYSIS OF VARIANCE; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; GENETICS; HEART; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANALYSIS OF VARIANCE; ANIMALS; BETA CATENIN; CARDIOTONIC AGENTS; COLLAGEN; HEART; HMGB1 PROTEIN; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; VENTRICULAR FUNCTION, LEFT; WNT PROTEINS;

EID: 84862270477     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/743879     Document Type: Article

References (25)

1. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T. B., Flegal K., Ford E., Furie K., Go A., Greenlund K., Haase N., Hailpern S., Ho M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M., Meigs J., Mozaffarian D., Nichol G., O'Donnell C., Roger V., Rosamond W., Sacco R., Sorlie P., Stafford R., Steinberger J., Thorn T., Wasserthiel-Smoller S., Wong N., Wylie-Rosett J., Hong Y., Heart disease and stroke statistics2009 update. A report from the American heart association statistics committee and stroke statistics subcommittee Circulation 2009 119 3 480 486
2. Lutgens E., Daemen M. J. A. P., De Muinck E. D., Debets J., Leenders P., Smits J. F. M., Chronic myocardial infarction in the mouse: cardiac structural and functional changes Cardiovascular Research 1999 41 3 586 593 (Pubitemid 29130622)
3. Kuizinga M. C., Smits J. F. M., Arends J. W., Daemen M. J. A. P., AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction Journal of Molecular and Cellular Cardiology 1998 30 2 425 434 (Pubitemid 28116322)
4. Lotze M. T., Tracey K. J., High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nature Reviews Immunology 2005 5 4 331 342 (Pubitemid 40516158)
5. Hu X., Zhou X., He B., Xu C., Wu L., Cui B., Wen H., Lu Z., Jiang H., Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats European Journal of Pharmacology 2010 638 13 84 89
6. Hu X., Jiang H., Cui B., Xu C., Lu Z., He B., Preconditioning with high mobility group box 1 protein protects against myocardial ischemia-reperfusion injury International Journal of Cardiology 2010 145 1 111 112
7. Wang L. J., Lu L., Zhang F. R., Chen Q. J., De Caterina R., Shen W. F., Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure European Journal of Heart Failure 2011 13 4 440 449
8. Harris H. E., Andersson U., The nuclear protein HMGB1 as a proinflammatory mediator European Journal of Immunology 2004 34 6 1503 1512 (Pubitemid 39256031)
9. Popovic P. J., DeMarco R., Lotze M. T., Winikoff S. E., Bartlett D. L., Krieg A. M., Guo Z. S., Brown C. K., Tracey K. J., Zeh H. J., High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists The Journal of Immunology 2006 177 12 8701 8707 (Pubitemid 44893835)
10. Huttunen H. J., Kuja-Panula J., Rauvala H., Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation The Journal of Biological Chemistry 2002 277 41 38635 38646 (Pubitemid 35154724)
11. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., Cossu G., Bianchi M. E., Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation Journal of Cell Biology 2004 164 3 441 449 (Pubitemid 38174771)
12. Limana F., Germani A., Zacheo A., Kajstura J., Di Carlo A., Borsellino G., Leoni O., Palumbo R., Battistini L., Rastaldo R., Mller S., Pompilio G., Anversa P., Bianchi M. E., Capogrossi M. C., Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circulation Research 2005 97 8 e73 e83
13. Brade T., Mnner J., Khl M., The role of Wnt signalling in cardiac development and tissue remodelling in the mature heart Cardiovascular Research 2006 72 2 198 209 (Pubitemid 44511910)
14. Clevers H., Wnt/ -catenin signaling in development and disease Cell 2006 127 3 469 480 (Pubitemid 44647433)
15. Reya T., Clevers H., Wnt signalling in stem cells and cancer Nature 2005 434 7035 843 850 (Pubitemid 40558990)
16. Blankesteijn W. M., Van Gijn M. E., Essers-Janssen Y. P. G., Daemen M. J. A. P., Smits J. F. M., -catenin, an inducer of uncontrolled cell proliferation and migration in malignancies, is localized in the cytoplasm of vascular endothelium during neovascularization after myocardial infarction American Journal of Pathology 2000 157 3 877 883 (Pubitemid 32109380)
17. Cohen E. D., Tian Y., Morrisey E. E., Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal Development 2008 135 5 789 798 (Pubitemid 351524132)
18. Takahashi K., Fukushima S., Yamahara K., Yashiro K., Shintani Y., Coppen S. R., Salem H. K., Brouilette S. W., Yacoub M. H., Suzuki K., Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation 2008 118 14 S106 S114
19. Ai Z., Fischer A., Spray D. C., Brown A. M. C., Fishman G. I., Wnt-1 regulation of connexin43 in cardiac myocytes The Journal of Clinical Investigation 2000 105 2 161 171 (Pubitemid 30054355)
20. Mirotsou M., Zhang Z., Deb A., Zhang L., Gnecchi M., Noiseux N., Mu H., Pachori A., Dzau V., Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair Proceedings of the National Academy of Sciences of the United States of America 2007 104 5 1643 1648 (Pubitemid 46214644)
21. Wharton K. A. Jr., Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction Developmental Biology 2003 253 1 1 17 (Pubitemid 36068000)
22. Chen L., Wu Q., Guo F., Xia B., Zuo J., Expression of Dishevelled-1 in wound healing after acute myocardial infarction: possible involvement in myofibroblast proliferation and migration Journal of Cellular and Molecular Medicine 2004 8 2 257 264 (Pubitemid 44145515)
23. Barandon L., Couffinhal T., Ezan J., Dufourcq P., Costet P., Alzieu P., Leroux L., Moreau C., Dare D., Dupla C., Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA Circulation 2003 108 18 2282 2289 (Pubitemid 37363048)
24. Wodarz A., Nusse R., Mechanisms of Wnt signaling in development Annual Review of Cell and Developmental Biology 1998 14 59 88 (Pubitemid 29001449)
25. Van Gijn M. E., Daemen M. J. A. P., Smits J. F. M., Blankesteijn W. M., The wnt-frizzled cascade in cardiovascular disease Cardiovascular Research 2002 55 1 16 24 (Pubitemid 34615937)